The NCRI Upper Gastrointestinal Group brings together clinicians, scientists and patients, carers and others affected by cancer (also known as ‘consumers’), amongst many others, to coordinate the development of a strategic portfolio of research within the field of upper gastrointestinal cancer. The group works closely with clinical research networks, funders and researchers to develop research to improve outcomes for upper gastrointestinal cancer patients.  

The NCRI Upper Gastrointestinal Group consists of an executive group, chaired by Professor John Bridgewaterwhich provides oversight of the research landscape and proactively identifies opportunities for the group. The NCRI Upper Gastrointestinal Group also has several subgroups that develop research in areas of strategic need. 

How can I get involved?

Join the NCRI Upper Gastrointestinal Network

Group members

Professor John Bridgewater

Chair

After qualifying in medicine and surgery in 1986, Professor Bridgewater specialised in medical on ...

Professor John Bridgewater

Chair

After qualifying in medicine and surgery in 1986, Professor Bridgewater specialised in medical oncology at the Middlesex, Mount Vernon and Royal Marsden Hospitals. He undertook a PhD in gene therapy at the Institute of Cancer Research, and subsequently took a senior lecturer position in medical oncology at UCL in 1999.

Dr Gwen Murphy

Deputy Chair

Dr Gwen Murphy is a Senior Research Fellow in the Cancer Screening and ...

Dr Gwen Murphy

Deputy Chair

Dr Gwen Murphy is a Senior Research Fellow in the Cancer Screening and Prevention Research Group (CSPRG) in the Department of Surgery and Cancer, Imperial College London.

Dr Murphy earned a PhD in Clinical Medicine from Trinity College Dublin, and a Masters in Public Health from University College Dublin before joining the Division of Cancer Epidemiology and Genetics (DCEG) at the National Cancer Institute (NCI) within the US National Institutes of Health (NIH). During her 13 years at the National Cancer Institute Dr Murphy worked to initiate the NCI International EBV-Gastric Cancer Consortium, was a founding member of the African Esophageal Cancer Consortium (AfrECC), coordinated a number of large international field studies of upper gastrointestinal cancers (China, Iran, Kenya, Brazil) and was a Steering Committee member for the Polyp Prevention Trial. Before joining the CSPRG Dr Murphy served as Executive Director at a health-tech start-up company.  

Her research program is focused on cancer prevention informed by etiologic investigations of gastrointestinal cancers in epidemiologic studies.